CD28

Source: Wikipedia, the free encyclopedia.
CD28
Gene ontology
Molecular function
Cellular component
Biological process
Sources:Amigo / QuickGO
Ensembl
UniProt
RefSeq (mRNA)

NM_001243077
NM_001243078
NM_006139

NM_007642

RefSeq (protein)

NP_001230006
NP_001230007
NP_006130

NP_031668

Location (UCSC)Chr 2: 203.71 – 203.74 MbChr 1: 60.76 – 60.81 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

CD28 (Cluster of Differentiation 28) is one of the

TCR) can provide a potent signal for the production of various interleukins (IL-6
in particular).

CD28 is the receptor for

antigen-presenting cells
(APCs). The CD86 expression on antigen-presenting cells is constitutive (expression is independent of environmental factors).

CD28 is the only

anergic
.

Furthermore, CD28 was also identified on bone marrow stromal cells, plasma cells, neutrophils and eosinophils, but the functional importance of CD28 on these cells is not completely understood.

memory T cells (TMs). In addition, the level of positive CD28 decreases with age.[9]

As a homodimer of two chains with Ig domains binds B7 molecules on APCs and it can promotes T cells proliferation and differentiation, stimulates production of growth factors and induces the expression of anti-apoptotic proteins.[10] According to several studies, after birth, all human cells express CD28. But in adult, 20-30% of CD8+ T cells lose the ability of CD28 expression, whereas in the elderly (+80 years) up to 50-60% of CD8+ cells lose the ability of CD28 expression.[11] But these statements only suggest that loss of CD28 expression marks functional differentiation to cytotoxic memory cells within clonal expansions.[12]

In general, CD28 is a primary costimulatory molecule for T cell activation. But effective co-stimulation is essential only for some T cell activation. In this case, in the absence of co-stimulatory signals, the interaction of dendritic and T cells leads to T cell anergy. The importance of the costimulatory pathway is underlined by the fact that antagonists of co-stimulatory molecules disrupt the immune responses both in vitro and in vivo.[13] But as mentioned earlier, during the course of activation e.g. TMs lose this molecule and assume a CD28-independent existence.[14]

Signaling

CD28 possesses an intracellular domain with several residues that are critical for its effective signaling. The YMNM motif beginning at

immune synapse
, which results in enhancement of IL-2 mRNA stability. Both are required for full production of IL-2.

CD28 also contains two

PKC-θ.[17]

Structure

The first structure of CD28 was obtained in 2005 by the T-cell biology group at the University of Oxford.[18]

The structure of the CD28 protein contains 220 amino acids, encoded by a gene consisting of four exons. It is a glycosylated, disulfide-linked homodimer of 44 kDa expressed on the cell surface. The structure contains paired domains of the V-set immunoglobulin superfamilies (IgSF). These domains are linked to individual transmembrane domains and cytoplasmic domains that contain critical signaling motifs.

CTLA4, CD28 share highly similar CDR3-analogous loops.[20] In the CD28-CD80 complex, the two CD80 molecules converge such that their membrane proximal domains collide sterically, despite the availability of both ligand binding sites for CD28.[18]

CD28 family members

CD28 belongs into group members of a subfamily of costimulatory molecules that are characterized by an extracellular variable immunoglobulin-like domain. Members of this subfamily also include homologous receptors

CTLA4, PD1, PD1H, and BTLA.[21] Nevertheless, only CD28 is expressed constitutively on mouse T cells, whereas ICOS and CTLA4 are induce by T cells receptor stimulation and in response to cytokines such as IL-2. CD28 and CTLA4 are very homologous and compete for the same ligand – CD80 and CD86.[22] CTLA4 binds CD80 and CD86 always stronger than CD28, which allows CTLA4 to compete with CD28 for ligand and suppress effector T cells responses.[23] But it was shown that CD28 and CTLA4 have opposite effect on the T cells stimulation. CD28 acts as a activator and CTLA4 acts as inhibitor.[24][25] ICOS and CD28 are also closely related genes, but they cannot substitute from one another in function. The opposing roles of CD28 and ICOS compared to CTLA4 cause that these receptors act as a rheostat for the immune response through competitive pro- and anti-inflammatory effects.[26]

As a drug target

The drug

It is known that CD28 and CTL4 may be critical regulators of autoimmune diseases in mouse model.[29][30] But there is less data from patients on the role of CD28 in human diseases.

Other potential drugs in pre-clinical development are agonist CD28 aptamers with immunostimulatory properties in a mouse tumor model,[31] a monoclonal anti-CD28 Fab´ antibody FR104,[32] or an octapeptide AB103, which prevents CD28 homodimerization.[33]

Interactions

CD28 has been shown to

interact
with:

See also

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000178562Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000026012Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. S2CID 22737782
    .
  6. .
  7. .
  8. .
  9. .
  10. .
  11. .
  12. .
  13. OCLC 1031053171.{{cite book}}: CS1 maint: location missing publisher (link
    )
  14. .
  15. .
  16. .
  17. .
  18. ^ .
  19. .
  20. .
  21. .
  22. .
  23. .
  24. .
  25. .
  26. .
  27. .
  28. .
  29. .
  30. .
  31. .
  32. .
  33. .
  34. .
  35. .
  36. .
  37. .

Further reading

External links

This page is based on the copyrighted Wikipedia article: CD28. Articles is available under the CC BY-SA 3.0 license; additional terms may apply.Privacy Policy